cell adhesion molecule

(redirected from Adhesion molecule)
Also found in: Medical, Acronyms, Wikipedia.

cell adhesion molecule

[¦sel ad‚hē·zhən ′mäl·ə·kyül]
(cell and molecular biology)
A class of membrane proteins comprising the outer surfaces of cell membranes in the developing nervous system that is thought to be intimately involved in guiding development during embryonic life. Abbreviated CAM.
References in periodicals archive ?
The sticky synapse; cell adhesion molecules and their role in synapse formation and maintenance.
Binding of circulating monocytes to vascular endothelial cells and their subsequent transendothelial migration into the subendothelial space are mediated by inducible cell adhesion molecules (CAMs) expressed on the surface of endothelial cells.
Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-KB activation in endothelial cells.
This process is mediated by cellular adhesion molecules such as sE-selectin, a specific product of endothelial cells.
Therefore, to obtain the total number of cells captured in the adhesion molecule coated flow device, we counted the number of cells in 20 randomly selected regions and multiplied by 72.
In this issue of The Journal of Applied Research, Zhang and coworkers explore the role of nitric oxide, adhesion molecule, and MCP-1 expression in arterial wall reorganization in response to carotid artery ligation (CAL).
53-57) The accumulation of ROS promotes the expression of intercellular adhesion molecules and subsequent neutrophil-endothelial cell adhesion.
Proinflammatory cytokines and cell adhesion molecules are elevated in both of these disorders.
The adhesion molecule E-cadherin and a surface antigen recognized by the antibody 9C4 are selectively expressed on erythroid cells of defined maturational stages.
com) announces updates to their Cell Adhesion Molecule research database.
19, 2011 /PRNewswire/ -- Selexys Pharmaceuticals announced today that it has completed a Phase I clinical study of its lead compound SelG1, an antibody specific for the pro-inflammatory cell adhesion molecule P-selectin.
The team also identified the adhesion molecule that functions as the cells' exit ticket.